Podcasts about laboratory testing

In this episode of the Integrative Health Podcast, Dr. Jen talks with Dr. Joseph Musto, a clinical laboratory science expert with over 50 years of experience. Dr. Musto discusses biotoxin illness and chronic inflammatory response syndrome (CIRS), explaining the role of MARCoNS testing in Dr. Shoemaker's CIRS protocol and the importance of eradicating these bacteria for recovery. He also shares practical advice for clinicians on treating MARCoNS, mold exposure, and biofilm infections, emphasizing the crucial role of lab testing in managing these complex conditions.  Dr. Joseph Musto is the President and Founder of Microbiology Dx, with over 50 years of experience in clinical laboratory science. A Board-Certified Clinical Laboratory Director, Dr. Musto has published more than 20 papers, co-authored seven patents, and developed key diagnostic methods, including those used in Dr. Shoemaker's protocol for biotoxin illness. He has held academic roles, including Associate Professor of Clinical Pathology, and serves as a consultant and laboratory director for multiple institutions. Dr. Musto's expertise spans clinical pathology, antimicrobial research, and innovative diagnostic testing, making him a leading figure in laboratory medicine. Thank you for listening please subscribe and share!- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -Shop supplements:https://healthybydrjen.shop/CHECK OUT a list of my Favorite products here:https://www.healthybydrjen.com/drjenfavoritesWATCH THIS:https://www.youtube.com/watch?v=2lSyAFy5U4U&list=PLaDiqj0yz1eeCOATXPoUDt8HEJxz1_lfW- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -FOLLOW ME:Instagram :: https://www.instagram.com/integrativedrmom/Facebook :: https://www.facebook.com/pflegmedTik Tok :: https://www.tiktok.com/@integrativedrjenYouTube :: https://www.youtube.com/@integrativedrmom- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -FTC: Some links included in PODCAST Thank you for listening please subscribe and share! - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Shop supplements: https://healthybydrjen.shop/ CHECK OUT a list of my Favorite products here: https://www.healthybydrjen.com/drjenfavorites WATCH THIS:https://www.youtube.com/watch?v=2lSyAFy5U4U&list=PLaDiqj0yz1eeCOATXPoUDt8HEJxz1_lfW - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - FOLLOW ME: Instagram :: https://www.instagram.com/integrativedrmom/ Facebook :: https://www.facebook.com/pflegmed Tik Tok :: https://www.tiktok.com/@integrativedrjen YouTube :: https://www.youtube.com/@integrativedrmom - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - FTC: Some links included in this description might be affiliate links. If you purchase a product through one of them, I will receive a commission (at no additional cost to you). I truly appreciate your support of my channel. Thank you for watching! Video is not spons...

Two-time Emmy and three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald, interviewed Sheila Michelle Foye.  Her career began with the Gas Company here in Atlanta just before natural gas was deregulated. She began as an Office Assistant and moved lattice style into mission-critical senior leadership roles within organizations and across industries such as SunTrust Banks (Truist), CapGemini, Accenture, Cox, and healthcare giants such as Morehouse School of Medicine, Piedmont, and Grady. Foye leveraged her corporate knowledge gained over the years to become an award winning, respected successful Entrepreneur in Drug Testing and CLIA-waived Laboratory Testing. Drug Testing was chosen due to her oldest son's murder (age 24), which was drug/ gang violence related and her family history of substance/alcohol abuse that made for a rocky road in life. Nearly two years into the business, Michelle was able to innovate and pivot Precis Screening by establishing a consulting arm that has now assisted more than 3,000 Entrepreneurs and counting. #BEST #AMI #STRAW #SHMSSee omnystudio.com/listener for privacy information.

Two-time Emmy and three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald, interviewed Sheila Michelle Foye.  Her career began with the Gas Company here in Atlanta just before natural gas was deregulated. She began as an Office Assistant and moved lattice style into mission-critical senior leadership roles within organizations and across industries such as SunTrust Banks (Truist), CapGemini, Accenture, Cox, and healthcare giants such as Morehouse School of Medicine, Piedmont, and Grady. Foye leveraged her corporate knowledge gained over the years to become an award winning, respected successful Entrepreneur in Drug Testing and CLIA-waived Laboratory Testing. Drug Testing was chosen due to her oldest son's murder (age 24), which was drug/ gang violence related and her family history of substance/alcohol abuse that made for a rocky road in life. Nearly two years into the business, Michelle was able to innovate and pivot Precis Screening by establishing a consulting arm that has now assisted more than 3,000 Entrepreneurs and counting. #BEST #AMI #STRAW #SHMSSee omnystudio.com/listener for privacy information.

Her career began with the Gas Company here in Atlanta just before natural gas was deregulated. She began as an Office Assistant and moved lattice style into mission-critical senior leadership roles within organizations and across industries such as SunTrust Banks (Truist), CapGemini, Accenture, Cox, and healthcare giants such as Morehouse School of Medicine, Piedmont, and Grady. Foye leveraged her corporate knowledge gained over the years to become an award winning, respected successful Entrepreneur in Drug Testing and CLIA-waived Laboratory Testing. Drug Testing was chosen due to her oldest son's murder (age 24), which was drug/ gang violence related and her family history of substance/alcohol abuse that made for a rocky road in life. Nearly two years into the business, Michelle was able to innovate and pivot Precis Screening by establishing a consulting arm that has now assisted more than 3,000 Entrepreneurs and counting. #STRAW #SHMSSupport the show: https://www.steveharveyfm.com/See omnystudio.com/listener for privacy information.

Her career began with the Gas Company here in Atlanta just before natural gas was deregulated. She began as an Office Assistant and moved lattice style into mission-critical senior leadership roles within organizations and across industries such as SunTrust Banks (Truist), CapGemini, Accenture, Cox, and healthcare giants such as Morehouse School of Medicine, Piedmont, and Grady. Foye leveraged her corporate knowledge gained over the years to become an award winning, respected successful Entrepreneur in Drug Testing and CLIA-waived Laboratory Testing. Drug Testing was chosen due to her oldest son's murder (age 24), which was drug/ gang violence related and her family history of substance/alcohol abuse that made for a rocky road in life. Nearly two years into the business, Michelle was able to innovate and pivot Precis Screening by establishing a consulting arm that has now assisted more than 3,000 Entrepreneurs and counting. #STRAW #SHMSSee omnystudio.com/listener for privacy information.

Laboratories in the United States are facing a major regulatory landscape shift. The U.S. Food and Drug Administration (FDA) has finalized a new rule ending its historical blanket enforcement discretion over laboratory developed tests (LDTs). What does this mean for labs going forward? On this episode, Epstein Becker Green attorneys James Boiani, Rob Wanerman, and Megan Robertson lay out the new landscape, analyze existing and potential challenges, and identify key developments to watch for as this new regulatory era unfolds. Visit our site for more information and related resources: https://www.ebglaw.com/dhc79 Subscribe for email notifications: https://www.ebglaw.com/subscribe. Visit: http://diagnosinghealthcare.com. This podcast is presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.

Adam is joined by Dr. Christoph Denk who runs Oceamo Labs, based out of Austria. Oceamo provides the most comprehensive ICP (MS) and laboratory testing for your tank water. Oceamo is the suggested testing method for Reef Moonshiners users. They go over Adam's recent ICP, looking in depth at each element, the dangers if elevated or depleted, toxicity levels and biological significance. They also discuss the various element inputs and sinks associated with our reef aquariums (watch out for GFO!).https://www.oceamo.com/https://www.facebook.com/OceamoLab/https://www.youtube.com/channel/UC9OJOnOuTFJmUj1y9TrE10w?view_as=subscriberhttps://www.instagram.com/oceamolab/https://www.reefmoonshiners.com/Frag Garage Links:https://www.patreon.com/BeyondTheReefPodcasthttps://fraggarage.ca/https://www.instagram.com/fraggarage/https://www.youtube.com/channel/UCLkiAJNqvoIRDRTFs34e6Twhttps://www.facebook.com/fraggarage Hosted on Acast. See acast.com/privacy for more information.

Jessica Kennedy, MD, Infectious Diseases Fellow at the University of South Florida Division of Infectious Diseases, discusses the scientific basics around many of the primary Infectious Diseases tests ordered by providers. Dr. Kennedy discusses the scientific basis for EIA/ELIZA, Quantiferon, chemiluminant immunoassays, lateral flow assays, RT-PCR, Fungitell, and LC/MS-MS. In explaining these diagnostic assays, Dr. Kennedy helps the provider understand the limitations and advantages of each test and when they are best used in a clinical scenario.

What to listen for:Our hosts Robin Greubel and Stacy Barnett dive headfirst into the high-stakes world of canine explosive detection with an esteemed panel of experts, Dr. Lauryn DeGreeff, Dr. Michele Maughan, and Jenna Gadberry. As they dissect the complexities of non-detonable canine training aids, you'll get a rare behind-the-scenes look at the intricate dance of odor chemistry and the safety measures paramount in training with both traditional and peroxide-based explosives. Safety for furry detectives and their handlers leads the charge in the discussion, as they navigate the laboratory and field labyrinth to analyze the effectiveness of different training aids.Ever pondered how a detection dog's nose works like a sophisticated bio-sensor, dissecting the world's odors? Our hosts and guests tackle the unfortunate issue of variability in training aids. With insights from Dr. Nathan Hall, they unravel the scent detection conundrum, especially when dealing with volatile compounds. Drawing from real-world applications and scientific scrutiny, this episode uncovers the essential need for multifaceted exposure and stringent training to enhance the fidelity of our four-legged bomb detectors.Key Topics:Explosives Dogs and Training Aids (0:02:04)Working with Green (naive to odor) Dogs (0:07:40)Dog Training Aids, Inconsistency, and Quality Control (0:12:38)Explosive TTP's (0:16:59)Training Aids for Explosive Detection Dogs (0:19:03)Training Aids and Quality Control (0:26:51)Canine Detection Capabilities and Training Aids (0:33:40)Risk Assessment around Canine Explosives Work (0:38:44)Explosives and Aids Aging (0:49:32)Canine Scent Detection and Research (0:58:22)Resources:Canines As The Original BioSensor & Odor/Scent Chemistry with Dr. Lauryn DeGreeffEvaluation of non-detonable canine training aids for explosives by headspace analysis and canine testingOSAC: Organization of Scientific Area Committees For Forensic ScienceNew Scientific Study About Bomb Dog Training (Podcast Episode)We want to hear from you:Check out the K9 Detection Collaborative FB page and comment on the episode post!K9Sensus Foundation can be found on Facebook and Instagram. We have a Trainer's Group on Facebook!Scentsabilities Nosework is also on Facebook. Here is a Facebook group you should join!Crystal Wing K9 Coach can be found here at CB K9 and here at Evolution Working Dog Club. Also, check out her Functional Obedience Class here.You can follow us for notifications of upcoming episodes, find us at k9detectioncollaborative.com

Wondering what the thyroid levels from your thyroid lab test mean? I'll break down what the different thyroid hormones indicate and dispel some misconceptions about which levels actually require medication.  If you have any additional questions you would like answered in the future, let me know in the comments! Watch/Read Next… Optimal Thyroid Levels: https://drruscio.com/optimal-thyroid-levels  Hyperthyroidism vs Hypothyroidism: https://drruscio.com/hyperthyroidism-vs-hypothyroidism/  Early Signs of Thyroid Problems: https://drruscio.com/what-are-early-warning-signs-of-thyroid-problems/  How to Get Off Thyroid Medication Naturally: https://drruscio.com/how-to-get-off-thyroid-medication/  Thyroid & Hair Loss: https://drruscio.com/thyroid-hair-loss/  Why Your Thyroid Diagnosis Might Be a MISDiagnosis: https://drruscio.com/thyroid-diagnosis/    Timestamps 00:00 Intro to the thyroid   03:57 TSH 05:02 Free T4  05:59 Free T3  07:07 TPO (thyroid antibodies)  08:13 Hashimoto's  10:00 TG (thyroglobulin)  12:58 Defining hypothyroidism 13:27 Defining hyperthyroidism  13:48 The grey area “Sluggish thyroid” 18:07 Treatments  20:20 Where symptoms can come from 24:25 Thyroid lab interpretation guide   Featured Studies  Physiology, Thyroid: https://pubmed.ncbi.nlm.nih.gov/30137850/  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III): https://pubmed.ncbi.nlm.nih.gov/11836274/  Serum thyrotrophin and circulating thyroglobulin and thyroid microsomal antibodies in a Finnish population: https://pubmed.ncbi.nlm.nih.gov/760358/  The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area: https://pubmed.ncbi.nlm.nih.gov/14558922/  Hypothyroidism Prevalence in the United States: A Retrospective Study Combining National Health and Nutrition Examination Survey and Claims Data, 2009-2019: https://pubmed.ncbi.nlm.nih.gov/36466005/  Correlation between sonography and antibody activity in patients with Hashimoto thyroiditis: https://pubmed.ncbi.nlm.nih.gov/24154902/  Laboratory Testing in Thyroid Conditions - Pitfalls and Clinical Utility: https://pubmed.ncbi.nlm.nih.gov/30215224/  Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment: https://pubmed.ncbi.nlm.nih.gov/35243857/  Anti-Thyroperoxidase Antibody Levels >500 IU/ml Indicate a Moderately Increased Risk for Developing Hypothyroidism in Autoimmune Thyroiditis: https://pubmed.ncbi.nlm.nih.gov/27607246/  Hyperthyroidism: https://pubmed.ncbi.nlm.nih.gov/32206604/  Subclinical Hypothyroidism: https://pubmed.ncbi.nlm.nih.gov/30725655/  Transient high thyroid stimulating hormone and hypothyroidism incidence during follow up of subclinical hypothyroidism: https://pubmed.ncbi.nlm.nih.gov/34879182/  Association of Thyroid Hormone Therapy With Quality of Life and Thyroid-Related Symptoms in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-analysis: https://pubmed.ncbi.nlm.nih.gov/30285179/  Treating hypothyroidism is not always easy: When to treat subclinical hypothyroidism, TSH goals in the elderly, and alternatives to levothyroxine monotherapy: https://pubmed.ncbi.nlm.nih.gov/34766382/  Symptoms Originally Attributed to Thyroid Dysfunction Were Instead Caused by Suboptimal Gastrointestinal Health: A Case Series and Literature Review: https://pubmed.ncbi.nlm.nih.gov/35999903/  The Relationship between Gastrointestinal Health, Micronutrient Concentrations, and Autoimmunity: A Focus on the Thyroid: https://pubmed.ncbi.nlm.nih.gov/36079838/  Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis: https://pubmed.ncbi.nlm.nih.gov/24224112/  Effects of vitamin D on thyroid autoimmunity markers in Hashimoto's thyroiditis: systematic review and meta-analysis: https://pubmed.ncbi.nlm.nih.gov/34871506/  Probiotics Ingestion Does Not Directly Affect Thyroid Hormonal Parameters in Hypothyroid Patients on Levothyroxine Treatment: https://pubmed.ncbi.nlm.nih.gov/29184537/    Get the Latest Updates Facebook - https://www.facebook.com/DrRusciodc Instagram - https://www.instagram.com/drrusciodc/ Pinterest - https://www.pinterest.com/drmichaelrusciodc    DISCLAIMER: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment or discontinuing an existing treatment. Music featured in this video: "Modern Technology" by Andrew G, https://audiojungle.net/user/andrew_g  *Full transcript available on YouTube by clicking the “Show transcript” button on the bottom right of the video.

We're thrilled to have Dr. Yusuf Saleeby on the podcast. He's a highly experienced medical professional, specializing in Integrative & Functional Medicine at Carolina Holistic Medicine in South Carolina. With a background in emergency medicine and various medical leadership roles, Dr. Saleeby brings a wealth of expertise to his current practice. He's also an active member of several prominent medical organizations including ILADS, IFM, A4M, ACAM, and the American Telehealth Association, where he focuses on Functional Medicine, research, and innovative healthcare models. If you are looking for an episode to provide insight on a variety of tools for chronic lyme disease, then this is the perfect episode! So many gems of information! Topics: 1. Lyme Disease Presentation and Diagnosis - Common Symptoms and Challenges - Under-diagnosis and Misdiagnosis Issues 2. Laboratory Testing for Lyme and Co-infections - Limitations of Standard Testing - The Role of Biomarker Laboratory Tests 3. Modified Treatment Protocols - Dr. Cowden's Approach - Dr. Buhner's Approach - Differences from Conventional Treatment 4. Low-Dose Naltrexone (LDN) in Lyme Treatment - Potential Benefits - Mechanisms of Action 5. Peptides in Chronic Lyme Treatment - Types of Peptides Used - Efficacy and Benefits 6. Timing and Phases of Peptide Administration - When Peptides Are Most Beneficial - Optimal Timing for Treatment 7. Some Aspects of His Treatment Protocol - Immune Support (Mushrooms, LDN, Thymosin Alpha-1) - Gut Support - Botanical Therapies (e.g., Cat's Claw) His Clinical website:  www.CarolinaHolisticMedicine.com His Substack:  www.jpsaleebymd.substack.com Thanks for tuning in! Get Chloe's Book Today! "⁠⁠⁠⁠⁠⁠⁠⁠75 Gut-Healing Strategies & Biohacks⁠⁠⁠⁠⁠⁠⁠⁠" If you liked this episode, please leave a rating and review or share it to your stories over on Instagram. If you tag @synthesisofwellness, Chloe would love to personally thank you for listening! Follow Chloe on Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@synthesisofwellness⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Chloe on TikTok @chloe_c_porter Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠synthesisofwellness.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to purchase products, subscribe to our mailing list, and more! Or visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠linktr.ee/synthesisofwellness⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to see all of Chloe's links, schedule a BioPhotonic Scanner consult with Chloe, or support the show! Thanks again for tuning in! --- Support this podcast: https://podcasters.spotify.com/pod/show/chloe-porter6/support

Throughout this series, we've talked about the growth of the direct access testing industry and the types of models developed to support the businesses that are using that type of testing. We've covered reimbursement considerations and physician ordering and specimen collection regulations. How does all of this come together to shape the future of the lab testing industry? On the final episode of our four-part series on direct access laboratory testing, Epstein Becker Green attorneys Bob Hearn, James Boiani, and Megan Robertson discuss licensing and operational considerations, as well as where the lab testing industry is headed.   Visit our site for more information and related resources: https://www.ebglaw.com/dhc70   Subscribe for email notifications: https://www.ebglaw.com/subscribe.   Visit: http://diagnosinghealthcare.com.   This podcast is presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.

In this episode of the Vibrant Wellness Podcast, Dr. Kevin Turner dives deep into functional medicine— inspired by his daughter's encounter with a pediatric neuropsychiatric condition. Joined by Dr. Kim Bruno, they discuss tickborne illnesses and related neuropsychiatric disorders in depth.They highlight the underestimated prevalence of tickborne infections and the challenges in treating Lyme disease, stressing the importance of comprehensive diagnosis and moving beyond just lab results. The discussion further expands on Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS), emphasizing the expertise needed to understand the multitude of factors affecting patients, especially when diagnosing adult PANS.The episode concludes with a compelling story of a woman's journey through, and recovery from, a tickborne disease. This story not only underscores the challenges of these illnesses but also brings hope to others facing similar situations. Dr. Turner details his treatment methods, including laser therapy, PEMF, and hyperbaric oxygen, highlighting the essential role of patient dedication.Tune in to understand the intertwined nature of tickborne diseases and their profound effects on neuropsychiatric well-being.Episode Chapters:(0:00:01) - Tickborne Illness and PANS Complexity(0:10:20) - Lyme Disease Treatment and Tick Illness(0:15:01) - Screening Patients and Utilizing Functional Medicine(0:25:49) - Understanding PANS and Autoimmune Encephalopathy(0:34:19) - Healthcare Mentorship and Case Reviews(0:43:53) - Wellness Centers and Vibrant Wellness PodcastLinks:Restorative Wellness Center: https://www.restorativechiro.com/Dr. Ashley Turner's Cookbooks: https://www.restorativechiro.com/drashleysbooksJoin Over 18,000 Leading Medical Professionals and Become a Vibrant Wellness Provider Today!

What if you could dive deeper into understanding pediatric tickborne diseases and their intersection with neuropsychiatric disorders? How could this knowledge benefit both healthcare professionals and families alike? In this enlightening podcast episode, we welcome Dr. Somer DelSignore, a renowned pediatric and adult Lyme and mental health specialist, to delve into these complex conditions.  As a former pediatric ICU nurse turned nurse practitioner, Dr. Somer has over 20 years of experience treating children with tickborne diseases and shares her journey into integrative medicine.In our conversation, we dive into the symptoms and challenges of diagnosing conditions such as Lyme disease, Babesia, and Bartonella, and explore the stealthy ways these bugs hide from treatment. Dr. Somer emphasizes the importance of laboratory testing and the differences between conventional and integrative treatment approaches, and shares her groundbreaking research on the connections between inflammation, mold, and immunity, and the role they play in pediatric tickborne diseases and neuropsychiatric disorders.We also discuss prevention techniques and natural alternatives to deet-based repellents, and resources for treating tickborne infections. Don't miss this insightful discussion with Dr. Somer DelSignore that will leave you better equipped to navigate the intricacies of pediatric tickborne diseases and neuropsychiatric disorders.Episode Chapters:(0:00:01) - Pediatric Tick-Borne Diseases and Neuropsychiatric Disorders(0:03:42) - Pediatric Lyme Disease Treatment(0:09:17) - Tick-Borne Illnesses and Co-Infections(0:22:44) - Lyme Disease Treatment and Complications(0:33:03) - Inflammation, Mold, and Immunity Connection(0:45:03) - Preventing and Treating Tick-Borne Infections(0:55:32) - Vibrant Wellness Podcast ReminderLinks:Hudson Valley IntegrativeJoin Over 18,000 Leading Medical Professionals and Become a Vibrant Wellness Provider Today!

Dr. Rade interviews Dr. Gonzalez about a range of topics including getting the most information possible from standard lab tests, optimal lab ranges, and the importance of muscle mass for overall health.   Dr. Gonzalez's website: https://www.drdaniel.com/about-dr-daniel-dc/   Dr. Gonzalez's Instagram page: https://www.instagram.com/drdanieldc/   To join Dr. Rade's mailing list to get free access to the first two parts of his Overcoming Chronic Illness Course: https://eastcoastnaturopathic.com/dr-bryan-rade-mailing-list   If you would like to have Dr. Rade consult on your case, please visit https://eastcoastnaturopathic.com/

A complex landscape of state laws overlays the direct access testing model, ranging from physician order requirements, such as telemedicine standards and the corporate practice of medicine doctrine, to specimen collection considerations, including how the varying options for collection could impact a model. How do these factors combine to create a roadmap for companies navigating the direct access testing industry? On the third episode of our four-part series on direct access laboratory testing, Epstein Becker Green attorneys Bob Hearn, Amy Lerman, and Megan Robertson discuss physician ordering and specimen collection considerations for direct access laboratory testing stakeholders.   Stay tuned for the final episode of our special series on direct access laboratory testing.   Visit our site for related resources and email contact information: https://www.ebglaw.com/dhc63.   Subscribe for email notifications: https://www.ebglaw.com/subscribe.   Visit: http://diagnosinghealthcare.com.   The EMPLOYMENT LAW THIS WEEK® and DIAGNOSING HEALTH CARE podcasts are presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.

Dr. Susan Audino is a chemist/chemometrician and independent consultant to chemical and biological laboratories. On behalf of Accreditation Bodies, she assesses laboratories and is an instructor for multiple ISO/IEC standards including ISO 17025. She is highly visible in the cannabis industry as a leader in the development of official/consensus test methods and quality in science and is a member of expert review panels. She also serves as a scientific advisor to multiple cannabis testing laboratories, private and non-profit cannabis organizations including Emerald Scientific and The Cannabis Science and Technology journal, and state regulatory bodies. Dr. Audino has chaired the AOAC cannabis advisory panel and analytical cannabis working groups was a member of the NCIA Guide for Laboratory Testing, is a faculty member of Teachable Medicine, a Board Member of Hood College, a Board Member of The Center for Research on Environmental Medicine, and has been an invited speaker at many domestic and international scientific conferences. Dr. Audino is a principal at S.A. Audino & Associates, LLC, a principal at RWD, LLC, a principal at Executive Quality Management, LLC, and Vice President & Sr. Science Officer at RCU Laboratories. Listen to on Spotify: https://open.spotify.com/show/2iHUi8B... MITA YOUTUBE https://www.youtube.com/@mitausa/featuredMITA Website https://mita.us/ MITA LINKEDIN https://www.linkedin.com/company/1828... MITA INSTAGRAM https://www.instagram.com/mitausa/ #mitausa #cannabisindustry #drsusanaudino

Welcome to the Paint The Medical Picture Podcast, created and hosted by Sonal Patel, CPMA, CPC, CMC, ICD-10-CM. Thanks to all of you for making this a Top 15 Podcast for 2 Years: https://blog.feedspot.com/medical_billing_and_coding_podcasts/ I'd love your continued support of this content-rich, value-add podcast to help you succeed in the business of medicine: https://podcasters.spotify.com/pod/show/sonal-patel5/support Sonal's 8th Season starts up and Episode 13 features her Newsworthy updates for the month's fraud, waste, and abuse cases. Trusty Tip features Sonal's compliance recommendations for the third CBR of 2023 - the CBR report issued on Laboratory Testing Urinalysis. Spark inspires us all to reflect on creativity based on the inspirational words of Pablo Picasso. Thanks to Advanced Coding Services, LLC: Website: https://advancedcodingservices.com/ Paint The Medical Picture Podcast now on: Spotify for Podcasters: https://podcasters.spotify.com/pod/show/sonal-patel5 Spotify: https://open.spotify.com/show/6hcJAHHrqNLo9UmKtqRP3X Apple Podcasts: https://podcasts.apple.com/us/podcast/paint-the-medical-picture-podcast/id1530442177 Google Podcasts: https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy8zMGYyMmZiYy9wb2RjYXN0L3Jzcw== Amazon Music: https://music.amazon.com/podcasts/bc6146d7-3d30-4b73-ae7f-d77d6046fe6a/paint-the-medical-picture-podcast Breaker: https://www.breaker.audio/paint-the-medical-picture-podcast Pocket Casts: https://pca.st/tcwfkshx Radio Public: https://radiopublic.com/paint-the-medical-picture-podcast-WRZvAw Find Paint The Medical Picture Podcast on YouTube: https://www.youtube.com/channel/UCzNUxmYdIU_U8I5hP91Kk7A Find Sonal on LinkedIn: https://www.linkedin.com/in/sonapate/ And checkout the website: https://paintthemedicalpicturepodcast.com/ If you'd like to be a sponsor of the Paint The Medical Picture Podcast series, please contact Sonal directly for pricing: PaintTheMedicalPicturePodcast@gmail.com --- Send in a voice message: https://podcasters.spotify.com/pod/show/sonal-patel5/message Support this podcast: https://podcasters.spotify.com/pod/show/sonal-patel5/support

When analyzing the lifecycle of any health care product, a key component to consider is how much the product will cost and who will pay for it. What unique challenges do direct access tests pose when it comes to reimbursement and related compliance requirements? On the second episode of our four-part series on direct access laboratory testing, Epstein Becker Green attorneys Bob Hearn and Megan Robertson and EBG Advisor Dr. Joel Brill discuss coverage and reimbursement for direct access tests, as well as the related compliance factors that labs, product developers, and investors in the diagnostic testing industry should be aware of.   Visit our site for related resources and email contact information: https://www.ebglaw.com/dhc59.   Subscribe for email notifications: https://www.ebglaw.com/subscribe.   Visit: http://diagnosinghealthcare.com.   The EMPLOYMENT LAW THIS WEEK® and DIAGNOSING HEALTH CARE podcasts are presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.

What are the various factors impacting stakeholders in the direct access testing industry? By the end of this four-part series on direct access laboratory testing, listeners will have gained insight into how to navigate the complex regulatory and legal regimes that govern the process of making lab tests available directly to patients and understand the aspects that will dictate how their operations should be structured. On this episode, Epstein Becker Green attorneys Amy Dow, Bob Hearn, James Boiani, and Megan Robertson discuss the regulatory landscape governing direct access laboratory testing.   Visit our site for related resources and email contact information: https://www.ebglaw.com/dhc58.   Subscribe for email notifications: https://www.ebglaw.com/subscribe.   Visit: http://diagnosinghealthcare.com.   The EMPLOYMENT LAW THIS WEEK® and DIAGNOSING HEALTH CARE podcasts are presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.

S2E5: Laboratory Testing Designed for the 21st Century with Pouria Sanae, CEO at iXLayer and host Dr. Nick. In 2015 at the start of Theranos, there were real companies and real solutions that did offer the potential to provide results from smaller samples that are easier and less painful to obtain. But many got caught in the fallout from the Theranos debacle and struggled to get any support or funding. There are better pain-limiting or pain-free solutions now and even specialized teams and technology helping that have improved the experience of giving blood. As you will hear this is something that is not always widely available or evenly distributed. But there are potential solutions and ones that might offer some of the value and provide a better approach to laboratory testing. Your better pill to swallow is to accelerate the delivery of wellness supported by widely available and distributed testing capability that is delivered to the individual at the time and place most convenient to them and their environment. Testing capabilities can and should be adapted to the patients that need it and not the other way around. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Our Laboratory Incubators from trusted brands. Whether gravity or mechanical convection. Incubator Applications, Bacterial Culturing and Research, hematology studies, Microbiological Determinations, Pharmaceutical Stability Assays. Get more information: https://www.globallabsupply.com/Incubators-Test-Chambers-s/2114.htm

Host Ericka Adler, Roetzel shareholder and Health Law Practice Group Leader, is joined by fellow Roetzel attorney Christina Kuta to discuss laboratory testing investigations related to the COVID-19 pandemic. Their in-depth discussion focuses on investigation outcomes and what these labs have failed to do properly, including having the correct CLIA status and inappropriate billing. Ericka and Christina then provide guidance on what providers should be mindful of if they are involved in COVID testing, along with expectations moving forward. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode of the #HealthLaw HotSpot, host Ericka Adler, Roetzel shareholder and Health Law Practice Group Leader, is joined by fellow Roetzel attorney Christina Kuta to discuss laboratory testing investigations related to the COVID-19 pandemic.  Their in-depth discussion focuses on investigation outcomes and what these labs have failed to do properly, including  having the correct CLIA status and inappropriate billing. Ericka and Christina then provide guidance on what providers should be mindful of if they are involved in COVID testing, along with expectations moving forward.

NASN School Nurse Editor, Cynthia Galemore, interviews authors Vicki Moran and Margaret Bultas about the article, "Laboratory Testing in the School Setting: Are You CLIA Compliant?". To view the article, click here.

Our Laboratory Incubators from trusted brands. Whether gravity or mechanical convection. Incubator Applications, Bacterial Culturing and Research, hematology studies, Microbiological Determinations, Pharmaceutical Stability Assays. Get more information: https://www.globallabsupply.com/Incubators-Test-Chambers-s/2114.htm

In this episode of RCA Radio, host Brandon Miller is joined by Dr. Matthew Jorgensen and Dr. Helin Räägel, Matt a board-certified toxicologist with a Ph.D. in chemistry and is Nelson Laboratory's Chemistry and Materials Scientist and Helin is Nelson Labs Senior Biocompatibility Expert with a Ph.D. in cell biology.Listen in as Matt and Helin help educate our listers about the world of pre-clinical testing/biocompatibility for medical devices by taking a deep dive into cytotoxicity testing of medical devices in this part of the Intro into Biocompatblity podcast series.About RCARegulatory Compliance Associates® Inc. (RCA) provides worldwide services to the following industries for resolution of compliance and regulatory challenges:PharmaceuticalBiologic & BiotechnologySterile compoundingMedical deviceWe understand the complexities of running a life science business and possess areas of expertise that include every facet of R&D, operations, regulatory affairs, quality, and manufacturing. We are used to working on the front lines and thriving in the scrutiny of FDA-and globally-regulated companies.As your partners, we can negotiate the potential minefield of regulatory, compliance, quality, and private equity due diligence with insight, hindsight, and the clear advantage of our unique expertise and experience.About Nelson LabsEvery year, hundreds of medical device, pharmaceutical, and tissue companies make Nelson Labs their testing laboratory of choice. For them, the decision is easy. Nelson Labs is a clear leader in the microbiology and analytical chemistry testing industry, offering more than 800 laboratory tests and employing more than 500 scientists and staff in state-of-the-art facilities. We are known for exceptional quality and rigorous testing standards, but it is our focus on the bigger picture that sets us apart. We look beyond test results and partner with you to achieve your long-term business goals — mitigating risk, being first to market, and succeeding with your customers.Companies choose Nelson Labs for our:Thought leaders and approachable experts. We give you direct access to industry authorities who understand your business and add value every step of the way.Customer-centric culture. We take the time to understand your vision. Your goals become our goals.Real-time project management tools and a dedicated client portal. We provide proactive information, keeping you informed and in control.Metric-driven testing processes. We're our own toughest customer, holding ourselves to goals exceeding 99% for things that matter most to you, like quality, turnaround time, and testing accuracy.Global compliance expertise and support. We act as a trusted advisor, helping you navigate the ever-changing compliance landscape.See how we can help you mitigate risk, be first to market, and succeed with your customers. 

S1E12: Local Healthcare needs Local Laboratory Testing with Gary Frazier, founder and CEO of Worksite Labs and host Dr. Nick. As the pandemic unfolded across our nation and world. timely testing revealed yet another crack in our healthcare services. Even prior to the pandemic the centralized nature of testing services was challenged to keep up with demand. The process of running a laboratory economically is a specialized task with some extreme pressures of staffing availability, supplies, regulatory compliance and integration into a frictionless patient experience. We need to create broader access to laboratory testing at the local level that goes beyond the home-based testing and basic testing services offered in physician offices. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode of RCA Radio, host Brandon Miller is joined by Dr. Matthew Jorgensen and Dr. Helin Räägel, Matt a board-certified toxicologist with a Ph.D. in chemistry and is Nelson Laboratory's Chemistry and Materials Scientist and Helin is Nelson Labs Senior Biocompatibility Expert with a Ph.D. in cell biology.Listen in as Matt and Helin help educate our listers about the world of pre-clinical testing/biocompatibility for medical devices. We cover the basic background of pre-clinical testing, explore the new things happening in the field, go over some best practices for testing, and then end with some advice on picking a testing lab for yourself.About RCARegulatory Compliance Associates® Inc. (RCA) provides worldwide services to the following industries for resolution of compliance and regulatory challenges:PharmaceuticalBiologic & BiotechnologySterile compoundingMedical deviceWe understand the complexities of running a life science business and possess areas of expertise that include every facet of R&D, operations, regulatory affairs, quality, and manufacturing. We are used to working on the front lines and thriving in the scrutiny of FDA-and globally-regulated companies.As your partners, we can negotiate the potential minefield of regulatory, compliance, quality, and private equity due diligence with insight, hindsight, and the clear advantage of our unique expertise and experience. 

Researcher and Biochemist Dr. David Zava joins this week's host Alannah Connealy to discuss female hormones, breast cancer and ZRT Lab testing. Topics they touch on include: Different methods of testing for female hormones Why maintaining a proper balance of hormones is particularly critical for women How hormones and stress play into breast cancer His book (linked below) on what you may not know about breast cancer Interview Links Book: https://amzn.to/3I2Aofh (What Your Doctor May Not Tell You About Breast Cancer) Website: https://www.zrtlab.com/about-us/our-founder-dr-david-zava/ (About Dr. David Zava) Where to Find Dr. Zava Website: https://www.zrtlab.com/ (ZRT Laboratory) Where to Find Host, Leigh Ann Lindsey https://www.theaccrescent.com/ (Website) https://www.instagram.com/leighannlindsey/ (Instagram) https://www.leighannlindsey.com/the-accrescent-podcast/ (The Accrescent Podcast)

Animal testing is a billion-dollar industry that uses legal loopholes to physically and mentally torture animals.That is why Melissa decided to become an Animal rights advocate and start her nonprofit. Beagle Freedom Project does everything from rescuing test subject animals to tackling legal battles.Melissa McWilliams, President and Founder of the Beagle Freedom Project, joins us to share her insights into the billion-dollar animal testing industry.Topics Include:Melissa's motivation to become an animal rights advocate.Dirty secrets of the animal testing industry.Emotional rehabilitation for test subject animals.Impact of COVID on the Beagle Freedom Project's operations. BFP's fostering and adoption criteria. And other topics...Resources Mentioned:Cruelty Cutter App: https://cruelty-cutter.org/BFP's Website: http://bfp.org/CUDDLY Blog: https://bit.ly/3p7MAoYWant to connect with us? Follow us on social media!Email – podcast@cuddly.comInstagram @welovecuddlyTwitter @welovecuddlyFacebook @welovecuddlyhttps://cuddly.com

From myths about how antibodies work to the accuracy of PCR, there are many misconceptions about vaccines, testing, and more. MLPAO CEO Michelle Hoad sat down with a panel of experts to discuss in-depth. She spoke with Dr. Zain Chagla, infectious diseases physician at St. Joseph's Healthcare in Hamilton; Dr. Rodney Rohde, Professor and Chair for the Clinical Laboratory Science (CLS) Program in the College of Health Professions at Texas State University; MLT Candy Rutherford, Technical Specialist Molecular Microbiology at Hamilton Health Sciences; and microbiologist and science educator Jason Tetro; to clear up some of the questions, misinformation, and inaccurate science around COVID-19 vaccines and laboratory testing.

In this episode, we talk to Anna M. Kotas, P.E., a technical sales and business development professional at GeoTesting Express (GTX), about how engineers can manage risk on geotechnical projects using quality laboratory testing programs. Engineering Quotes: Here Are Some of the Questions We Ask Anna: Why is good quality laboratory testing data important, and […] The post TGEP 32: Managing Risk on Geotechnical Projects Through Quality Laboratory Testing Programs appeared first on Engineering Management Institute.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., consider how laboratory medicine will continue to evolve to meet health care needs beyond the COVID-19 pandemic.

The CAP’s Accuracy-Based programs use genuine human specimens that exhibit essentially no matrix effects. Such samples can be used to compare different methods to each other and to reference methods. In so doing, pathologists and laboratory professionals can assess whether the method used in their laboratories is accurate, not just that your performance matches your peer group. In this CAPcast, Gary Horowitz, MD, FCAP, Chair of the CAP’s Accuracy-Based Programs Committee, explains why it’s important to incorporate accuracy-based testing into your quality process. For more information about the CAP’s Accuracy-Based programs, please visit https://capatholo.gy/3qtcJMF.

In this episode, Elli Theel, Ph.D., director of the infectious diseases serology laboratory and co-director of the vector-borne diseases service line at Mayo Clinic, discusses some of the nitty-gritty details when it comes to the COVID-19 vaccine and laboratory testing.

Welcome to Ask Stago, the weekly podcast for Hemostasis laboratory professionals. This week, with our expert Frédéric Brutto, product line manager, Cécile Hourquet and Audrey Carlo will question HIL interferences and how the coagulation laboratory can handle them. Sources: Lippi G et al., Interference of blood cell lysis on routine coagulation testing. Arch Pathol Lab Med. 2006;130(2):181-4 Woolley A et al., Effects of haemolysis, icterus and lipaemia on coagulation tests as performed on Stago STA-Compact-Max analyser. Int J Lab Hematol. 2016; 38(4): 375-88 Plebani M, Quality Indicators to Detect Pre-Analytical Errors in Laboratory Testing, Clin Biochem Rev 2012; 3: 85-88. Salvagno GL et al, Prevalence and type of pre-analytical problems for inpatients samples in coagulation laboratory, J Eval Clin Pract. 2008 ;14(2):351-3. CLSI Hemolysis, Icterus, and Lipemia/Turbidity Indices as Indicators of Interference in Clinical Laboratory Analysis; Approved Guideline. CLSI document C56-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2012 CLSI Collection, Transport and Processing of Blood Specimens for Testing Plasma-based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline – Fifth Edition. CLSI Document H21-A5; Wayne, PA: Clinical and Laboratory Standards Institute; 2008

This episode is shared from Answers from the Lab and was originally published June 25, 2020.  Guest: William G. Morice, II M.D., Ph.D. (@moricemdphd)  Host: Bobbi S. Pritt, M.D. (@ParasiteGal)  William Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and President of Mayo Clinic Laboratories, joins the Answers from the Lab podcast for his weekly leadership update. In this episode, Dr. Morice discusses the future of testing for COVID-19, predicting who would be at the highest risk for severe disease, and challenges with existing diagnostics.  AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19  Connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd 

In this episode, Jennifer Rodemeyer, Manager of the Child Life Program at Mayo Clinic, discusses the importance of explaining laboratory testing, especially to young patients and their families, to help patients cope with medical procedures such as COVID-19 testing.

William Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and President of Mayo Clinic Laboratories, joins the Answers from the Lab podcast for his weekly leadership update. On this episode, Dr. Morice discusses the future of testing for COVID-19, predicting who would be at the highest risk for severe disease, and challenges with existing diagnostics.

EMplify May 2020-  Mt Sinai COVID-19 Protocols - Dr. Legome   Contact us: emplify@ebmedicine.net 1-678-336-8466, ext. 128   Emergency Department COVID Management Protocols: One Institution’s Experience and Lessons Learned Laboratory Testing and Imaging Disposition/admission Criteria Cardiac Arrest Protocol Medication Treatment Guidelines Anticoagulation Protocol Intubation Protocol Nonaerosolized Asthma Protocol Acute Dyspnea/Palliative Care Treatment Death Management Talking Points COVID-19 Smart Phrases / Discharge Plan for Likely COVID-19 Patients Guidelines for Prone Positioning of Nonintubated Patients Critical Care for ED COVID-19 Patients

Acute Gastroenteritis- Author: Dr. Brian Geyer Introduction: Do both vomiting and diarrhea have to be present? No 1996 AAP guidelines, 2016 ACG guidelines, and 2017 IDSA guidelines all note diarrhea illness but may be vomiting predominant. Studies use more vague definitions like: > 1 episode of vomiting and/or > 3 episodes of diarrhea in 24 hours without known chronic cause like inflammatory bowel disease. Diarrhea is at least 3 unformed stools per day. Acute episode 29 days Patients in the ED may present with only some of these symptoms depending their time in course of illness. Literature Review: There is abundant literature on pediatric AGE but sparse research on AGE in adults. Therefore, many recommendations are extrapolated from the pediatric literature. Causes: 70% of US cases are estimated to be caused by viruses, norovirus being most common. o 26% norovirus o 18% rotavirus Among bacterial causes: o 5.3% Salmonella, most common o 5.3% Clostridium o 3% Campylobacter o 3% parasitic infections Large portion, 51%, have no cause identified. (In ED patients) Interestingly, 79% of cases never have a cause identified (not ED specific) In ED patients, only 25% ever have a cause identified, this increases to 49% when a stool sample is obtained. (not ED specific) Food poisoning is responsible for 5% of AGE but results in 30% of deaths. Most commonly: Salmonella, Clostridium perfringens, and Campylobacter Majority of foodborne illness is still viral, mostly norovirus E Coli is normal in the gut, but two most common causes are: Shiga toxin Ecoli (STEC) AKA enterohemorrhagic Ecoli (EHEC) - causes Hemolytic Uremic Syndrome in 5-10% Entertoxigenic Ecoli (ETEC) - causes traveler's diarrhea Both cause self-limited illness. Alternate Diagnoses: Appendicitis: In the peds literature, misdiagnosis of appendicitis as AGE leads to 47% absolute increased risk of perforation. Suggestive findings include: Migration of pain to RLQ RLQ tenderness on exam (initial or repeat) Absence of diarrhea Pain not improved with episodes of diarrhea Negative factors include multiple ill family members, recent international travel, presence of diarrhea (as defined above). Ciguatera Fish Poisoning Toxin produced by algae consumed by reef fish like grouper, red snapper, sea bass and Spanish mackerel. Symptoms begin 6-24 hours post ingestion. Fish tastes normal. Patients may develop neurological symptoms like paresthesias, generalized pruritis, and reversal of hot/cold sensation. Symptoms resolve spontaneously, and treatment with mannitol is controversial. Scombroid Poisoning Ingesting fish in the Scombroidae family - mackerel, bonito, albacore, and skipjack - that have been stored improperly Bacteria produce histidine decarboxylase which converts histidine to histamine Causes abdominal cramps and diarrhea, and may cause metallic bitter or peppery taste in mouth, and facial flushing within 20-30 min of ingestion Can be confused with allergic reaction Symptoms resolve in 6-8 hours Notification of health dept may prevent others from being infected. Page 5 Table 1- Distinguishing Factors in the Differential Diagnosis of AGE History: Table 2, page 6 has key questions to ask. Onset, timing, number of stools, presence of blood, fever, quality of abdominal pain and location, recent antibiotics, etc. Extremes of age, immunosuppression, and pregnancy should be identified. Mortality is highest in the patients >65 yo. Physical Exam: We talked about RLQ abd pain, but what about bloody stool? An observational study of 889 adults and 151 pediatric with AGE showed that a negative fecal occult test showed accurately excluded invasive bacterial etiology with a NPV 87% in adults and 96% in children. But PPV was only 24%. Laboratory Testing and Imaging: Dehydration is the biggest contributor to mortality, especially in the very young and elderly. Lab evaluation for dehydration is recommended in these populations. No consistent association between lab abnormalities and bacterial etiology. WBC and differential does not differentiate bacterial vs viral, but may help in identifying severity of illness. Hemoglobin and platelets are helpful if HUS is suspected. Stool Cultures: 2017 IDSA guidelines recommends them in patients with fever, bloody or mucoid stools, severe abdominal cramping or tenderness, or signs of sepsis, noting these patients are at higher risk of bacterial infection. Specifically, Salmonella, shigella, Campylobacter, and Yersinia 2016 ACG guidelines recommend them for patients with watery diarrhea and moderate to severe illness with fever for at least 72 hours. Consider them for immunocompromised patients and those with recent abx use or hospitalization. C Difficile testing is recommended for all patients with AGE who are age >2 with a history of recent abx use or recent hospitalization Blood cultures are recommended for patients

Supporting the compliance, transparency, and growth of cannabis businesses with Ashley Manning (Business Development Manager) and Adrienne Uthe (VP Sales & Marketing) for the National Association of Cannabis Businesses. Today we learn about the First Self-Regulatory Organization for the U.S. Cannabis Industry, the National Association of Cannabis Businesses. The NACB’s mission is supporting the compliance, transparency, and growth of cannabis businesses in the U.S. Led by a team of government, legal, banking, and data security experts, the NACB helps member businesses establish voluntary national standards that address critical issues such as advertising and financial integrity. Licensed owners of a cannabis dispensary, grower, or any other ancillary business may apply to become a member. The NACB recently announced the adoption of National Standards on Laboratory Testing and Product Integrity. These standards are designed to protect consumers and demonstrate to regulators and the public that NACB members operate at the highest levels of ethics and responsibility, especially when it comes to the safety and quality of their products. They include limits to permissible potency variances for THC and CBD, independence of labs from control and business interests of test subjects, required accreditation for testing methodologies, verifiability of claims regarding contaminants and testing Integrity and honesty of sampling procedures.

Supporting the compliance, transparency, and growth of cannabis businesses with Ashley Manning (Business Development Manager) and Adrienne Uthe (VP Sales & Marketing) for the National Association of Cannabis Businesses. Today we learn about the First Self-Regulatory Organization for the U.S. Cannabis Industry, the National Association of Cannabis Businesses. The NACB’s mission is supporting the compliance, transparency, and growth of cannabis businesses in the U.S. Led by a team of government, legal, banking, and data security experts, the NACB helps member businesses establish voluntary national standards that address critical issues such as advertising and financial integrity. Licensed owners of a cannabis dispensary, grower, or any other ancillary business may apply to become a member. The NACB recently announced the adoption of National Standards on Laboratory Testing and Product Integrity. These standards are designed to protect consumers and demonstrate to regulators and the public that NACB members operate at the highest levels of ethics and responsibility, especially when it comes to the safety and quality of their products. They include limits to permissible potency variances for THC and CBD, independence of labs from control and business interests of test subjects, required accreditation for testing methodologies, verifiability of claims regarding contaminants and testing Integrity and honesty of sampling procedures.

A work horse laboratory in any functional medicine practice is stool testing. But really gleaning the best insight into our patient’s clinical picture can be tough. What do all of these commensal organisms really suggest? How do they correlate with the inflammatory findings? Of the bell weather bugs (like akkermansia) how can we increase levels? Is there ANY place for microscopy (O&P) and culture in today’s high throughput Omics world? You see where I’m headed. Even for the most seasoned FxMed clinician, a review of how to use these tests with an eye towards what to expect in new technology is essential. Disagreement with methods? Yes. Why? Zonulin Family Peptide – any utility? A great conversation with Dr. Michael Chapman of Genova Diagnostics. Thrilled with their commitment to in-house “data mining” and peer reviewed publication (IMO all of the Fx labs should be doing this). ~DrKF

Overutilization of laboratory services is an important unresolved issue in health care.  A recent study that appears in the September 2019 issue of Clinical Chemistry attempts to address this issue.  That paper titled ” Once-Per-Visit Alerts: A Means to Study Alert Compliance and Reduce Repeat Laboratory Testing,” examined reorders of a laboratory test within the same admission. 

Join our Guest Host, Kevin Hersh with guests Dr. Nam Tran (UC Davis), and Dr. Chris Newhouse (Roche) as they discuss the Role of Diagnostics In Supporting Antibiotic Stewardship Goals. Dr. Newhouse will be introducing Antibiotic Resistance with Dr. Tran who will be discussing Antibiotic Stewardship in Action followed with a group discussion on the role of Diagnostics in Antibiotic Stewardship.

Join our Guest Host, Kevin Hersh with guests Dr. Nam Tran (UC Davis), and Dr. Chris Newhouse (Roche) as they discuss the Role of Diagnostics In Supporting Antibiotic Stewardship Goals. Dr. Newhouse will be introducing Antibiotic Resistance with Dr. Tran who will be discussing Antibiotic Stewardship in Action followed with a group discussion on the role of Diagnostics in Antibiotic Stewardship.

In this episode, our panel of experts discuss the global harmonization of laboratory testing and its impact on the end-stage renal disease community.

Hepatitis C virus or HCV infection affects close to 150 million people worldwide.  In the U.S., it is estimated that as many as five million people have been infected with the Hepatitis C virus, many of whom are unaware of their infection.  HCV is now the most common indication for liver transplantation, and it accounts for more deaths each year than all other reportable infectious diseases combined including HIV. Advances in testing methods and antiviral therapies with increased development of infrastructures that improve access care now make eradication of HCV infection in well-resourced countries a realistic goal.  However, challenges in implementing screening programs and continues evolution of assay methods and screening protocols raise several issues for how clinicians and laboratories respond to the changing landscape for HCV diagnosis and treatment.  The December 2017 issue of Clinical Chemistry includes a Q&A article with several experts who offer their insights and opinions on this topic.

Chief of the Bureau of Cannabis Control for California, Lori Ajax returns by phone on the day that the first temporary licenses have been granted. The Bureau is directly responsible for Distribution, Retailer, Laboratory Testing and Microbusiness licenses. Manufacturing licenses are directly granted by the California Department of Public Health and were also on track. Cultivation licenses are being granted by the California Department of Food and Agriculture and aiming to be granted just prior to Jan. 1st. At the time of the interview on 12/14/17, Lori takes us through the fact that there are roughly 1,900 applicants in the temporary licensing system and the Bureau is on track to deal with all of them on time. She continues with what to expect between January 1st and July 1st 2018.

In this podcast, which is a short segment from a comprehensive interview about sepsis I had with infectious disease physician, Steven LaRosa, MD this past weekend on the radio show, I pulled out an interesting segment on his views of what laboratory tests he found useful in the diagnosis of sepsis. In the segment, LaRosa goes into quite a bit of detail on the Complete Blood Count, or CBC and looks at all the useful information a physician can get out of the very common laboratory test.

In this podcast, which is a short segment from a comprehensive interview about sepsis I had with infectious disease physician, Steven LaRosa, MD this past weekend on the radio show, I pulled out an interesting segment on his views of what laboratory tests he found useful in the diagnosis of sepsis. In the segment, LaRosa […] The post Laboratory testing and sepsis appeared first on Outbreak News Today.

We caught up with Maria Alice Willrich, Ph.D., who presented a mid-day short course on Monday, July 31. The course was titled, "The Complement System: Overview and Laboratory Testing" and she co-presented with a colleague from the University of Colorado, Ashley Frazer-Abel, Ph.D.

Bryan Timmins - Adrenal Testing and Biohealth Labs - Podcast #140 Get Show Updates Here: http://www.beyondwellnessradio.com/newsletter You-tube Podcast Subscribe: http://www.youtube.com/subscription_center?add_user=justinhealth Show Transcription: See https://justinhealth.com/bryan-timmins-adrenal-testing-and-biohealth-labs-podcast-140 Watch and listen to Dr. Justin Marchegiani and Bryan Timmins, one of the founders of BioHealth Laboratory, as they discuss about the different tests the BioHealth Laboratory have and are famous for. They also discuss about the Cortisol Awakening Response and how stress and other similar factors affect the HPA Axis. To get the full information on Bryan Timmin's thought about Chronic Stress and Laboratory Testing, explore and watch it in this podcast. In this episode, we will cover: 1:31 Glucose versus Lactulose Test 10:00 How BioHealth came to be. 15:27 Cortisol Awakening Response 20:49 How Waking Affects One's HPA Axis 33:30 Sleep as the Next Microbomb Subscribe on I-Tunes: http://www.beyondwellnessradio.com/itunes Review us at: http://www.beyondwellnessradio.com/itunes Visit us at: http://www.beyondwellnessradio.com Have a question: http://www.beyondwellnessradio.com/question References: http://biohealthlab.com https://www.facebook.com/biohealthlab twitter.com/biohealth https://www.youtube.com/user/biohealth Free eBook: The Chronic Stress Crisis

Acute cholecystitis is a diagnosis that we make frequently in the Emergency Department. But like all diagnostic work ups there is a lot to know about which parts of the history, examination and bedside tests we can do in the ED that really help either rule in or rule out the disease. In this podcast we run through some of the key bits of information published in the Commissioning Guide Gallstone disease 2016, jointly published by the Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland & the Royal College of Surgeons. We then concentrate on a recent systematic review of the diagnostic work up for Acute Cholecystitis. Yet again the evidence base brings up some issues to challenge our traditional teaching on the topic but should help polish our management of patients with a differential of Acute Cholecystitis. Enjoy! References & Further Reading Commissioning Guide Gallstone disease 2016 Up to date; Acute Cholecystitis NICE guidance; Acute Cholecystitis History, Physical Examination, Laboratory Testing, and Emergency Department Ultrasonography for the Diagnosis of Acute Cholecystitis. Jain A. Acad Emerg Med

Pazoo specializes in laboratory testing of cannabis and cannabinoids to ensure quality and consistency that protects consumers from impurities, contaminants and other irregularities. We learn more about Pazoo with CEO David Cunic.

Commentary by Dr. Valentin Fuster

The Dog Show #286 – August 20, 2014 Beagle Freedom Project – Organization that places beagles, dogs and other animals from laboratory testing into loving forever homes. Get their Cruelty Cutter App so you can stop buying products that are … Read More

Pazoo specializes in laboratory testing of cannabis and cannabinoids to ensure quality and consistency that protects consumers from impurities, contaminants and other irregularities. We learn more about Pazoo with CEO David Cunic.